• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

多种轻度凝血因子缺乏对凝血酶原时间和活化部分凝血活酶时间的矛盾效应。

Paradoxic effect of multiple mild coagulation factor deficiencies on the prothrombin time and activated partial thromboplastin time.

作者信息

Burns E R, Goldberg S N, Wenz B

机构信息

Department of Laboratory Medicine, Albert Einstein College of Medicine, Bronx, New York 10461.

出版信息

Am J Clin Pathol. 1993 Aug;100(2):94-8. doi: 10.1093/ajcp/100.2.94.

DOI:10.1093/ajcp/100.2.94
PMID:8356955
Abstract

Single coagulation factor deficiencies predictably prolong the prothrombin time (PT) and activated partial thromboplastin time (APTT) at levels below 35% of normal activity. Acquired coagulopathies generally are characterized by multiple coagulation factor deficiencies. The effect was studied of such combined deficiencies on the PT/APTT using plasma from patients congenitally deficient in specific factors and pooled normal plasma. The PT begins to lengthen when individual factor levels fall below 25%. The APTT becomes prolonged when the levels of Factor V fall below 45%; the levels of Factors II and XI fall below 40%; and the levels of Factors I, V, VII, VIII, IX, and XII fall below 25% of normal. When plasma samples containing 50% activity of a single factor and 100% of all other factors were prepared by mixing the congenitally deficient plasma samples with the normal pool, the resulting mixtures had normal PT and APTT values. However, when two of these 50% factor-deficient plasmas were combined so that the mixture contained 75% activity of two coagulation factors and 100% of all other factors, the resulting PT and APTT were prolonged over the clotting times of either 50% factor-deficient plasma. Similar findings were obtained in patients with mild factor reductions caused by warfarin treatment. These data indicate that prolongations of the PT and APTT in disorders of coagulation affecting multiple factors represent less of a reduction in factor levels than is generally appreciated. This may explain the poor clinical correlation between abnormalities in these test results and clinical bleeding in acquired disorders of hemostasis.

摘要

单一凝血因子缺乏在活性低于正常水平的35%时可预测地延长凝血酶原时间(PT)和活化部分凝血活酶时间(APTT)。获得性凝血病通常以多种凝血因子缺乏为特征。使用先天性特定因子缺乏患者的血浆和混合正常血浆,研究了这种联合缺乏对PT/APTT的影响。当单个因子水平降至25%以下时,PT开始延长。当因子V水平降至45%以下;因子II和XI水平降至40%以下;因子I、V、VII、VIII、IX和XII水平降至正常的25%以下时,APTT延长。通过将先天性缺乏血浆样本与正常混合血浆混合制备含有单一因子50%活性和所有其他因子100%活性的血浆样本时,所得混合物的PT和APTT值正常。然而,当将两个50%因子缺乏的血浆合并,使混合物含有两种凝血因子75%的活性和所有其他因子100%的活性时,所得的PT和APTT比任何一种50%因子缺乏血浆的凝血时间都延长。在华法林治疗导致因子轻度降低的患者中也获得了类似的结果。这些数据表明,在影响多种因子的凝血障碍中,PT和APTT的延长所代表的因子水平降低程度比一般认为的要小。这可能解释了这些检测结果异常与获得性止血障碍临床出血之间较差的临床相关性。

相似文献

1
Paradoxic effect of multiple mild coagulation factor deficiencies on the prothrombin time and activated partial thromboplastin time.多种轻度凝血因子缺乏对凝血酶原时间和活化部分凝血活酶时间的矛盾效应。
Am J Clin Pathol. 1993 Aug;100(2):94-8. doi: 10.1093/ajcp/100.2.94.
2
On-site prothrombin time, activated partial thromboplastin time, and platelet count. A comparison between whole blood and laboratory assays with coagulation factor analysis in patients presenting for cardiac surgery.现场凝血酶原时间、活化部分凝血活酶时间及血小板计数。心脏手术患者全血检测与实验室检测及凝血因子分析的比较。
Anesthesiology. 1994 Feb;80(2):338-51. doi: 10.1097/00000542-199402000-00014.
3
Effect of lipoprotein-associated coagulation inhibitor (LACI) on thromboplastin-induced coagulation of normal and hemophiliac plasmas.脂蛋白相关凝血抑制剂(LACI)对凝血活酶诱导的正常血浆和血友病血浆凝血的影响。
Thromb Res. 1991 Oct 15;64(2):213-22. doi: 10.1016/0049-3848(91)90120-l.
4
Mixing Studies in Patients With Prolonged Activated Partial Thromboplastin Time or Prothrombin Time.混合研究在患有延长的活化部分凝血活酶时间或凝血酶原时间的患者中。
Anesth Analg. 2019 Jun;128(6):1089-1096. doi: 10.1213/ANE.0000000000003457.
5
Coagulation Testing in the Core Laboratory.核心实验室中的凝血检测
Lab Med. 2017 Nov 8;48(4):295-313. doi: 10.1093/labmed/lmx050.
6
Do PT and APTT sensitivities to factors' deficiencies calculated by the H47-A2 2008 CLSI guideline reflect the deficiencies found in plasmas from patients?按照2008年CLSI H47 - A2指南计算的PT和APTT对凝血因子缺乏的敏感度是否反映了患者血浆中发现的凝血因子缺乏情况?
Int J Lab Hematol. 2015 Dec;37(6):853-60. doi: 10.1111/ijlh.12424. Epub 2015 Sep 4.
7
Factor V Deficiency因子V缺乏症
8
Comparison of a chromogenic prothrombin time with clotting prothrombin time in the assessment of clinical coagulation deficiencies.在评估临床凝血缺陷时,显色凝血酶原时间与凝血凝血酶原时间的比较。
Am J Clin Pathol. 1985 Dec;84(6):724-9. doi: 10.1093/ajcp/84.6.724.
9
Assessment of Actin FS and Actin FSL sensitivity to specific clotting factor deficiencies.评估肌动蛋白FS和肌动蛋白FSL对特定凝血因子缺乏症的敏感性。
Clin Lab Haematol. 1998 Jun;20(3):179-86. doi: 10.1046/j.1365-2257.1998.00122.x.
10
Evaluation of bedside prothrombin time and activated partial thromboplastin time measurement by coagulation analyzer CoaguCheck Plus in various clinical settings.
Thromb Res. 1997 Sep 1;87(5):431-40. doi: 10.1016/s0049-3848(97)00159-x.

引用本文的文献

1
Variation in coagulation factor activity levels cause discrepancies between activated partial thromboplastin time and anti-Xa activity for heparin monitoring: a retrospective observational study.凝血因子活性水平的变化导致活化部分凝血活酶时间与用于肝素监测的抗Xa活性之间存在差异:一项回顾性观察研究。
J Intensive Care. 2023 Nov 16;11(1):54. doi: 10.1186/s40560-023-00701-3.
2
Point-of-care platelet function testing for guided transfusion in neurosurgical management of intracranial hemorrhage: a systematic review.即时血小板功能检测在颅内出血神经外科管理中指导输血的应用:系统评价。
Eur J Med Res. 2022 Oct 1;27(1):191. doi: 10.1186/s40001-022-00819-4.
3
[Coagulation diagnostics in the clinical routine-Part 1 : Evaluation of the risk of bleeding before surgery, interventions and diagnostics in bleeding diathesis].
临床常规中的凝血诊断——第1部分:手术前出血风险评估、出血性疾病的干预措施及诊断方法
Inn Med (Heidelb). 2022 Jun;63(6):619-630. doi: 10.1007/s00108-022-01331-x. Epub 2022 May 18.
4
A phase I, first-in-human, randomized dose-escalation study of anti-activated factor XII monoclonal antibody garadacimab.一项抗活化因子 XII 单克隆抗体 garadacimab 的 I 期、首次人体、随机剂量递增研究。
Clin Transl Sci. 2022 Mar;15(3):626-637. doi: 10.1111/cts.13180. Epub 2021 Dec 3.
5
Effect of plasma component transfusion on conventional coagulation screening tests.血浆成分输血对传统凝血筛查试验的影响。
Asian J Transfus Sci. 2018 Jan-Jun;12(1):57-61. doi: 10.4103/ajts.AJTS_24_17.
6
Adding up the evidence: Trigger for prophylactic plasma transfusion.综合证据:预防性血浆输注的触发因素。
Asian J Transfus Sci. 2017 Jul-Dec;11(2):214-215. doi: 10.4103/ajts.AJTS_63_16.
7
Thromboelastometry versus standard coagulation tests versus restrictive protocol to guide blood transfusion prior to central venous catheterization in cirrhosis: study protocol for a randomized controlled trial.血栓弹力图与标准凝血试验及限制性方案在肝硬化患者中心静脉置管术前指导输血的比较:一项随机对照试验的研究方案
Trials. 2017 Feb 27;18(1):85. doi: 10.1186/s13063-017-1835-5.
8
Clinical relevance of isolated prolongation of the activated partial thromboplastin time in a cohort of adults undergoing surgical procedures.在接受手术的成年人队列中,孤立的活化部分凝血活酶时间延长的临床意义。
Blood Transfus. 2017 Oct;15(6):557-561. doi: 10.2450/2016.0047-16. Epub 2016 Jul 22.
9
Clinical presentation and blood gas analysis of multiple trauma patients for prediction of standard coagulation parameters at emergency department arrival.多发伤患者到达急诊科时的临床表现及血气分析对标准凝血参数的预测作用
Anaesthesist. 2016 Apr;65(4):274-80. doi: 10.1007/s00101-016-0150-y. Epub 2016 Apr 8.
10
Plasma is ineffective in correcting mildly elevated PT-INR in critically ill children: a retrospective observational study.血浆在纠正危重症儿童轻度升高的 PT-INR 方面无效:一项回顾性观察研究。
J Intensive Care. 2014 Nov 29;2(1):64. doi: 10.1186/s40560-014-0064-1. eCollection 2014.